Subscribe to RSS
DOI: 10.1055/s-0044-1791941
Welcome to Seminars in Thrombosis and Hemostasis 2025: Toward the Next 50 Years of Publishing and Announcement of New Online Manuscript Submission System

As we head toward 2025, and another year of publishing Seminars in Thrombosis & Hemostasis (STH), it is once again my privilege to welcome the reader to the new year. As noted widely in several past editorials, STH was first published in 1974,[1] and so 2024 marked the 50th birthday of STH. Therefore, 2025 will mark the first year that STH enters the next phase, or the second 50 years of publishing. The year 2025 will also mark my 17th year anniversary as Editor in Chief, so I can say with confidence that I am still a relative teenager! Eberhard F. Mammen steered the journal from its inception in 1974 to his passing in 2008, so 34 years. At 17 years, I guess I may have reached the halfway point, although I doubt I will reach the 34-year mark. In any case, a half century of STH publishing represented a landmark worthy of celebration. We started the celebrations in 2022 when we published our first “toward” 50 years celebratory issue.[2] A second celebratory issue was published in 2023, again marking a “toward” 50 years celebratory issue.[3] We published two issues in 2024 to mark the actual 50th year anniversary of STH publishing.[4] [5] All issues were rich with thrombosis and hemostasis themed content of a historical nature, and all issues were well received by our readers. Indeed, several papers from these issues were listed in our most recent most popular download lists.[6] [7]
Publication History
Article published online:
17 October 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 The first issue of STH. Accessed September 27, 2024 at: https://www.thieme-connect.com/products/ejournals/issue/10.1055/s-012-55744
- 2 Favaloro EJ. Celebrating 50 years of Seminars in Thrombosis and Hemostasis: part I. Semin Thromb Hemost 2022; 48 (08) 871-874
- 3 Favaloro EJ. Celebrating 50 years of Seminars in Thrombosis and Hemostasis: part II. Semin Thromb Hemost 2023; 49 (03) 212-216
- 4 Favaloro EJ. Celebrating 50 years of Seminars in Thrombosis and Hemostasis: part III. Semin Thromb Hemost 2024; 50 (01) 4-7
- 5 Favaloro EJ. Celebrating 50 years of Seminars in Thrombosis and Hemostasis: part IV. Semin Thromb Hemost 2024; 50 (05) 677-681
- 6 Favaloro EJ. 2024 Eberhard F. Mammen Award Announcements: part I—most popular articles. Semin Thromb Hemost 2024; 50 (07) 919-932
- 7 Favaloro EJ. 2023 Eberhard F. Mammen Award Announcements: part I—most popular articles. Semin Thromb Hemost 2023; 49 (05) 417-426
- 8 Favaloro EJ. Welcome to Seminars in Thrombosis and Hemostasis 2024: 50 years of publishing. Semin Thromb Hemost 2024; 50 (01) 1-3
- 9 Kwaan HC. The pathogenesis of thrombotic thrombocytopenic purpura. Semin Thromb Hemost 1979; 5 (03) 184-198
- 10 Professor Anne-Mette Hvas is the new dean of the Faculty of Health at Aarhus University. Accessed September 27, 2024 at: https://newsroom.au.dk/en/news/show/artikel/professor-anne-mette-hvas-is-the-new-dean-of-the-faculty-of-health-at-aarhus-university/
- 11 ISTH Announces new Editors for its Flagship Publication, the Journal of Thrombosis and Haemostasis. Accessed September 27, 2024 at: https://www.isth.org/news/633949/ISTH-Announces-new-Editors-for-its-Flagship-Publication-the-Journal-of-Thrombosis-and-Haemostasis.htm
- 12 Smock KJ, Gosselin RC. Laboratory diagnostics for thrombosis and hemostasis testing: part I. Semin Thromb Hemost 2022; 48 (06) 631-633
- 13 Smock KJ, Gosselin RC. Laboratory diagnostics for thrombosis and hemostasis testing: part II. Semin Thromb Hemost 2023; 49 (06) 569-570
- 14 Smock KJ, Moffat KA. Laboratory diagnostics for thrombosis and hemostasis testing-part 3. Semin Thromb Hemost 2024; 50 (08) 1047-1048
- 15 Hvas AM, Larsen JB, Pasalic L. Thrombosis and hemostasis in surgery. Semin Thromb Hemost 2017; 43 (07) 649-652
- 16 Hvas AM, Larsen JB, Pasalic L. Acquired platelet dysfunction-laboratory and clinical implications. Semin Thromb Hemost 2020; 46 (03) 235-237
- 17 Larsen JB, Lisman T, Hvas AM. Preface: altered fibrinolysis—clinical impact and diagnostic challenges. Semin Thromb Hemost 2021; 47 (05) 477-479
- 18 Gyldenholm T, Larsen JB. Cancer-associated thrombosis and beyond: biomarkers, treatments, and cancer-hemostasis interactions. Semin Thromb Hemost 2024; 50 (03) 325-327
- 19 Harenberg J, Stehle G, Augustin J, Zimmermann R. Comparative human pharmacology of low molecular weight heparins. Semin Thromb Hemost 1989; 15 (04) 414-423
- 20 Glycosaminoglycans: I. Guest Editors: J. Harenberg MD & B. Casu Ph.D. Accessed September 27, 2024 at: https://www.thieme-connect.com/products/ejournals/issue/10.1055/s-002-7584
- 21 Othman M. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes. Semin Thromb Hemost 2007; 33 (08) 780-786
- 22 Othman M. Molecular genetic testing in hemostasis and thrombosis: the past, the present, and the future. Semin Thromb Hemost 2008; 34 (06) 485-489
- 23 Schulman S, Islam MS. Recent advances in thrombosis and hemostasis: part I. Semin Thromb Hemost 2016; 42 (08) 805-807
- 24 Favaloro EJ. New Seminars in Thrombosis and Hemostasis 2022 impact factor, most highly cited papers, and other journal metrics. Semin Thromb Hemost 2023; 49 (07) 661-669
- 25 Favaloro EJ, Lippi G. Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): part I. Semin Thromb Hemost 2020; 46 (07) 757-762
- 26 Favaloro EJ, Lippi G. Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): part II. Semin Thromb Hemost 2021; 47 (04) 333-337
- 27 Favaloro EJ, Lippi G. Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): part III. Semin Thromb Hemost 2022; 48 (01) 3-7
- 28 Favaloro EJ, Pasalic L, Lippi G. Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19): part IV. Semin Thromb Hemost 2023; 49 (01) 3-8
- 29 Turner S, Naidoo CA, Usher TJ. et al. Increased levels of inflammatory and endothelial biomarkers in blood of long COVID patients point to thrombotic endothelialitis. Semin Thromb Hemost 2024; 50 (02) 288-294
- 30 Pretorius E, Kell DB. A perspective on how fibrinaloid microclots and platelet pathology may be applied in clinical investigations. Semin Thromb Hemost 2024; 50 (04) 537-551